© Copyright RiverVest® All Rights Reserved.
/ PORTFOLIO
San Diego, CA
Avalyn is a clinical-stage biotech company developing novel inhaled formulations of established oral antifibrotic medicines. The approach is designed to deliver these drugs directly to the lungs, where they are needed, reducing systemic side effects for patients with pulmonary fibrosis.
(Nasdaq: AVLN)